CD4 and neoplasm: Here we found that in vivo chronic mirtazapine treatment could inhibit the tumor growth and prolong the survival of tumor-bearing mice, which showed increased serum IL-12 level, CD4+, CD8+ in the lymph nodes, as well as serotonin transporters in the brain, and decreased TNF-α and IFN-γ in the tumors.